Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (21442)	5/27/1998 4:09:00 PM
From: Hippieslayer	Read Replies (2) \| Respond to of 32384

It's not negative, Andrew. It's called ballance or more like objectivity. Many people are long ligand but can see things that people like you can't see. They just don;t look at ligand as a great company with potential products, but as a trading stock. Try to get that thru your thick head. None of you snake oil salesmen have yet to identify what exactly others have said about ligand that is negative. Based on my recollection, I know of no one that has questioned lgnd's science. Some, including I, have commented on the weakness of ligand's stock compared to other weak (in trials and drugs in the pipeline) biotechs that have moved up with news, but that's it. SO what exactly is your gripe? And why do you take this stock so personally?